1. Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling
   Shuo Chen et al, 2020, Frontiers in Oncology CrossRef
2. Indomethacin prevents TGF-β-induced epithelial-to-mesenchymal transition in pancreatic cancer cells; evidence by Raman spectroscopy
   Gulay Sezer et al, 2022, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
3. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines
   HOISEON JEONG et al, 2014, Oncology Reports CrossRef
4. The role of TGF-β in the tumor microenvironment of pancreatic cancer
   Qiang Luo et al, 2023, Genes & Diseases CrossRef
5. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
   Jiangang Zhao et al, 2017, Stem Cells International CrossRef
6. Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment
   Carole Y. Perrot et al, 2013, Pharmacology & Therapeutics CrossRef
7. Understanding the colon cancer stem cells and perspectives on treatment
   Elsa N Garza-Treviño et al, 2015, Cancer Cell International CrossRef
8. Caffeic Acid Phenethyl Ester Inhibits Epithelial-Mesenchymal Transition of Human Pancreatic Cancer Cells
   Ming-Jen Chen et al, 2013, Evidence-Based Complementary and Alternative Medicine CrossRef
9. TNFα and TGFβ-1 synergistically increase the cancer stem cell properties of MiaPaCa-2 cells
   Aikyn Kali et al, 2017, Oncology Letters CrossRef
10. TGF-β/Smad2/3 Signaling Directly Regulates Several miRNAs in Mouse ES Cells and Early Embryos
    Nicholas Redshaw et al, 2013, PLoS ONE CrossRef
11. Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and Oncopromotion
    G. K. Chimal-Ramírez et al, 2013, Journal of Oncology CrossRef
12. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
    Silvia Ottaviani et al, 2018, Nature Communications CrossRef
13. TGF-beta signaling in cancer radiotherapy
    Juan Wang et al, 2021, Cytokine CrossRef
14. Characterization of the Impact of the MYBBP1A Gene and rs3809849 on Asparaginase Sensitivity and Cellular Functions
    Rachid Abaji et al, 2022, Pharmacogenomics CrossRef
15. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
    Pingting Zhou et al, 2017, Molecular Cancer CrossRef
16. TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment
    Mai Abdel Mouti et al, 2021, Molecular Therapy CrossRef
17. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
    Divya Thomas et al, 2019, Molecular Cancer CrossRef
18. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
    Murielle Mimeault et al, 2014, Molecular Aspects of Medicine CrossRef
19. A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
    Paula M. Schmidtlein et al, 2021, Cancers CrossRef
20. Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
    Paula Marie Schmidtlein et al, 2021, Cancers CrossRef
21. Unveiling the role of microRNA‐7 in linking TGF‐β‐Smad‐mediated epithelial‐mesenchymal transition with negative regulation of trophoblast invasion
    Jin‐Chung Shih et al, 2019, The FASEB Journal CrossRef
22. HDAC3 mediates smoking-induced pancreatic cancer
    Mouad Edderkaoui et al, 2016, Oncotarget CrossRef